ALSgeneScanner: a pipeline for the analysis and interpretation of DNA NGS data of ALS patients
Alfredo IacoangeliiD, Ahmad Al KhleifatiD, William SprovieroiD, Aleksey ShatunoviD, Ashley R. Jones, Sarah Opie-MartiniD, Ersilia Naselli, Simon D. ToppiD, Isabella FoghiD, Angela HodgesiD, Richard DobsoniD, Stephen NewhouseiD, Ammar Al‐ChalabiiD
Abstract
Amyotrophic lateral sclerosis (ALS, MND) is a neurodegenerative disease of upper and lower motor neurons resulting in death from neuromuscular respiratory failure, typically within two years of first symptoms. Genetic factors are an important cause of ALS, with variants in more than 25 genes having strong evidence, and weaker evidence available for variants in more than 120 genes. With the increasing availability of Next-Generation sequencing data, non-specialists, including health care professionals and patients, are obtaining their genomic information without a corresponding ability to analyse and interpret it. Furthermore, the relevance of novel or existing variants in ALS genes is not always apparent. Here we present ALSgeneScanner, a tool that is easy to install and use, able to provide an automatic, detailed, annotated report, on a list of ALS genes from whole genome sequence data in a few hours and whole exome sequence data in about one hour on a readily available mid-range computer. This will be of value to non-specialists and aid in the interpretation of the relevance of novel and existing variants identified in DNA sequencing data.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 14
- FWCI
- 1.35
- Field percentile
- top 21%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The Project MinE databrowser: bringing large-scale whole-genome sequencing in ALS to researchers and the public
Rick A. A. van der Spek, Wouter van Rheenen, … on behalf of the Project MinE ALS Sequencing Consortium·Amyotrophic Lateral Sclerosis and Frontotemporal DegenerationPeer-reviewed·Jul 3, 2019
- The oligogenic structure of amyotrophic lateral sclerosis has genetic testing, counselling, and therapeutic implications
Alfredo Iacoangeli, Allison Ann Dilliott, … Sali M.K. Farhan·Journal of Neurology Neurosurgery & PsychiatryPeer-reviewed·Feb 13, 2025
- Rare variant analyses validate known ALS genes in a multi-ethnic population and identifies ANTXR2 as a candidate in PLS
Tess D. Pottinger, Joshua E. Motelow, … Matthew B. Harms·medRxiv·Sep 30, 2023
- Mitochondrial genome variants associated with Amyotrophic Lateral Sclerosis and their haplogroup distribution
Marcelo R. S. Briones, João H. C. Campos, … James Riley Broach·Muscle & NervePeer-reviewed·Aug 9, 2024
- Genome-wide Identification of the Genetic Basis of Amyotrophic Lateral Sclerosis
Sai Zhang, Johnathan Cooper‐Knock, … Michael P. Snyder·NeuronPeer-reviewed·Jan 18, 2022
- Evaluating the utility of REVEL and CADD for interpreting variants in amyotrophic lateral sclerosis genes
Michael R. Fiorini, Allison Ann Dilliott, Sali M.K. Farhan·Human MutationPeer-reviewed·Nov 13, 2023